제17806호                                관              보                 2012. 7. 18.(수요일)
        1. Decides to amend part I of Annex A of the Convention to list lindane therein with
a specific exemption for the use of lindane as a human health pharmaceutical for the control of
head lice and scabies as second line treatment by inserting the following row:
          Chemical               Activity        Specific exemption
          Lindanel*              Production      None
          CAS No: 58-89-9 Use                    Human
                                                 head lice health  pharmaceutical
                                                            and scabies as second for     control of
                                                                                    line treatment
        2. Requests the Secretariat to cooperate with the World Health Organization in
developing reporting and reviewing requirements for the use of lindane as a human health
pharmaceutical for the control of head lice and scabies, taking into consideration the concluding
statement in the Persistent Organic Pollutants Review Committee's risk management evaluation
on lindane, and to report on that cooperation to the Conference of the Parties at its fifth meeting.
SC-4/16: Listing of pentachlorobenzene
        The Conference of the Parties,
        Having considered the risk profile, addendum to the risk profile and risk management
evaluation for pentachlorobenzene transmitted by the Persistent Organic Pollutants Review
Committee,31)
        Taking note of the recommendation by the Persistent Organic Pollutants Review
Committee to pentachloroenzene in Annex A of the Convention without specific exemption and in
Annex C of the Convention,32)
        1. Decides to amend part I of Annex A of the Convention to list pentachlorobenzene
therein without specific exemptions by inserting the following row:
          Chemical              Activity       Specific exemption
          Lindanel*             Production None
          CAS No: 58-89-9 Use                  Human
                                               lice and health
                                                         scabiespharmaceutical
                                                                  as second line for   control of head
                                                                                 treatment
        2. Also decides to amend part I of Annex C of the convention to list
pentachlorobenzene therein by inserting pentachlorobenzene (PeCB) (CAS No:608-93-5) in the
"Chemical" table after "Polychlorinated dibenzo-p-dioxin and dibenzofurans (PCDD/PCDF)" and by
inserting "pentachlorobenzene" into the first paragraph of part II and part III of Annex C after
"Polychlorinated dibenzo-p-dioxin and dibenzofurans".
SC-4/17: Listing of perfluorooctane sulfonic acid, its salts and perfluorooctane sulfonyl
fluoride
        The Conference of the Parties,
        Having considered the risk profile, management evaluation and addendum to the risk
management evaluation for 33)perfluorooctane sulfonate transmitted by the Persistent Organic
Pollutants Review Committee,
        Taking note of the recommendation by the Persistent Organic Pollutants Review
Committee to list perfluorooctane sulfonic acid, its salts and perfluorooctane sulfonyl fluoride in
Annex A or Annex B of the Convention,34)
        1. Decides to amend part I of Annex B of the Convention to list perfluorooctane
sulfonic acid, its salts and perfluorooctane sulfonyl fluoride therein by inserting the following row,
with the acceptable purposes and specific exemptions specified in the row:
  31)    UNEP/POPS/POPRC.3/20/Add.7, UNEP/POPS/POPRC.4/15/Add.5. and
        UNEP/POPS/POPRC.4/15/Add.2.
  32)    UNEP/POPS/COP.4/17.
  33)    UNEP/POPRC.2/17/Add.5, UNEP/POPRC.3/20/Add.5. and UNEP/POPRC.4/15/Add.6.
  34)    UNEP/POPS/COP.4/17.
                                                 120